YS Biopharma (YSB) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisChartEarningsFinancialsHeadlinesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for YS Biopharma (NASDAQ:YSB)CurrentInstitutional OwnershipPercentage52.64%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$254.53KNumber ofInstitutional Sellers(last 12 months)0 Get YSB Insider Trade Alerts Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data YSB Institutional Buying and Selling by Quarter Ad Weiss RatingsTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. YS Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/5/2024 Ovata Capital Management Ltd150,000$153K0.1%N/A0.161% 2/14/2024 Superstring Capital Management LP307,920$166K0.1%N/A0.331% 9/21/2023Barclays PLC108,894$150K0.0%N/A0.423% 8/14/2023 Prelude Capital Management LLC32,200$44K0.0%N/A0.125% 5/16/2023 Snow Lake Management LP1,811,942$2.90M1.7%N/A7.037% 5/16/2023 Hhlr Advisors LTD.751,790$1.20M0.0%N/A2.920% 5/15/2023 RTW Investments LP341,090$546K0.0%N/A1.325% 5/11/2023 FIL Ltd2,718,499$4.35M0.0%N/A10.557% 5/10/2023 Valliance Asset Management Ltd1,607,175$2.57M4.6%N/A6.241% (Data available from 1/1/2016 forward) YSB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of YSB shares? During the previous two years, 9 institutional investors and hedge funds held shares of YS Biopharma. The most heavily invested institutionals were FIL Ltd ($4.35M), Snow Lake Management LP ($2.90M), Valliance Asset Management Ltd ($2.57M), Hhlr Advisors LTD. ($1.20M), RTW Investments LP ($546K), Superstring Capital Management LP ($166K), and Ovata Capital Management Ltd ($153K).Learn more on YSB's institutional investors. What percentage of YS Biopharma stock is owned by institutional investors? 52.64% of YS Biopharma stock is owned by institutional investors. Learn more on YSB's institutional investor holdings. Which institutional investors have been buying YS Biopharma stock? Of the 9 institutional investors that purchased YS Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FIL Ltd ($2.72M), Snow Lake Management LP ($1.81M), Valliance Asset Management Ltd ($1.61M), Hhlr Advisors LTD. ($751.79K), RTW Investments LP ($341.09K), Superstring Capital Management LP ($307.92K), and Ovata Capital Management Ltd ($150K). How much institutional buying is happening at YS Biopharma? Institutional investors have bought a total of 7,829,510 shares in the last 24 months. This purchase volume represents approximately $12.02M in transactions. Related Companies ARS Pharmaceuticals Institutional Ownership Gyre Therapeutics Institutional Ownership Mesoblast Institutional Ownership ANI Pharmaceuticals Institutional Ownership Arcutis Biotherapeutics Institutional Ownership Cassava Sciences Institutional Ownership Calliditas Therapeutics AB (publ) Institutional Ownership Zymeworks Institutional Ownership Avadel Pharmaceuticals Institutional Ownership Bicara Therapeutics Institutional Ownership This page (NASDAQ:YSB) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share YS Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free YSB Stock Alerts